Ad copy

Moshy is 100% online. That means easy telehealth appointments, no pharmacy queues, and no need to wait for a GP. ✅ Access GLP-1 treatments ✅ Personalised weight loss support ✅ Discreet delivery to your door ✅ All from the comfort of home ** Wegovy®, a GLP-1 receptor agonist, is prescription medicine containing semaglutide, indicated for use as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with a BMI ≥30 (obese) or ≥27 to <30 (overweight) in the presence of at least one weight-related comorbidity. Wegovy® has risks and benefits. Ask your doctor if it is right for you. Use only as directed by your healthcare professional. If you experience any side effects, speak to your doctor, pharmacist or healthcare provider. Wegovy® is not funded in New Zealand - pharmacy and doctor charges apply. For more information, see the Consumer Medicine Information on www.medsafe.govt.nz. Hairmop NZ Limited, Auckland.